Gain Therapeutics: Q4 Earnings Insights

Comments
Loading...

Gain Therapeutics GANX reported its Q4 earnings results on Tuesday, March 26, 2024 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Gain Therapeutics beat estimated earnings by 9.0%, reporting an EPS of $-0.29 versus an estimate of $-0.32.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 4.0% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Gain Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

GANX Logo
GANXGain Therapeutics Inc
$1.80-7.69%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum45.61
Growth-
Quality-
Value-
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: